Man Group’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$3.78M Buy
2025
Q1
$1.74M Buy
2024
Q4
$676K Buy
2024
Q3
$467K Buy
2023
Q2
Hold
2023
Q1
Hold
2020
Q1
Sell
2019
Q4
$84K Buy